newsfilter
← Latest News
ACCESS Newswire·

CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement

HOUSTON, TX / ACCESSWIRE / September 12, 2024 / CNS Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the development of novel treatments for